EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Thermally Gated Dual‐Cascade Nanozyme for Enhanced Mild‐Temperature Photothermal Therapy

Shuyu Wang, Shenghui Wang, Mengyuan Cao, Lulu Wang, Wei Jiang, Xiyun Yan, Ying Liu, Bing Jiang iD

Advanced Science · 2026

DOI: 10.1002/advs.202517528 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, 2026. Verfasst von Shuyu Wang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Nanozyme Laboratory in Zhongyuan, School of Basic Medical Sciences, Zhengzhou University, Zhengzhou, 450001, China. Hauptthemen laut MEDLINE: Photothermal Therapy. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Mild‐temperature photothermal therapy (mPTT) is attractive for cancer treatment due to its safety and precision but is limited by heat shock protein 70 (HSP70)‐mediated thermotolerance, which allows tumor cells to survive sublethal heating. Herein, a thermo‐responsive cascade nanozyme system is reported (Ru‐GOx‐PNN) that enhances mPTT through dual suppression of HSP70. This system integrates a Ru‐doped porous carbon framework that serves as both an efficient NIR photothermal transducer and a catalytic nanozyme with intrinsic peroxidase (POD)‐ and catalase (CAT)‐like activities, immobilized glucose oxidase (GOx) to initiate metabolic oxidation and supply H 2 O 2 , and an outer thermosensitive PNN hydrogel that gates substrate access and exposes active sites specifically within the mPTT window. Upon mild heating, the GOx‐POD cascade generates hydroxyl radicals that trigger lipid peroxidation and destabilize HSP70, while the GOx‐CAT cascade consumes glucose and reduces adenosine triphosphate synthesis, further suppressing HSP70 expression. The resulting inhibition of HSP70 relieves its restraint on c‐Jun N‐terminal kinase signaling, thereby amplifying apoptosis. Collectively, this strategy effectively overcomes thermal resistance and enhances the therapeutic efficacy of mPTT. This study highlights the potential of cascade catalytic nanozymes as intelligent platforms for safe, efficient, and precise tumor therapy, particularly in challenging malignancies such as esophageal squamous cell carcinoma (ESCC).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Photothermal TherapyHSP70 Heat-Shock ProteinsAnimalsHumansGlucose OxidaseMiceCell Line, TumorTemperature

Stichwörter der Autor:innen

cascade catalytic nanozymeheat shock protein 70mild‐temperature photothermal therapythermo‐responsive behaviortumor catalytic therapy

Substanzen

HSP70 Heat-Shock ProteinsGlucose Oxidase

Autor:innen und Institutionen

  • Nanozyme Laboratory in Zhongyuan, School of Basic Medical Sciences, Zhengzhou University, Zhengzhou, 450001, China.
  • National Health Commission Cardiovascular Disease Regenerative Medicine Research Key Laboratory, Central China Subcenter of National Center for Cardiovascular Diseases, Henan Cardiovascular Disease Center, Fuwai Central…
  • Nanozyme Laboratory in Zhongyuan, Henan Academy of Innovations in Medical Science, Zhengzhou, Henan, 451163, China.
  • CAS Engineering Laboratory for Nanozyme, Key Laboratory of Biomacromolecules, Institute of Biophysics, Chinese Academy of Sciences, Beijing, 100101, China.

ORCID-Profile: Bing Jiang

Zitieren

APA

Wang, S., Wang, S., Cao, M., Wang, L., Jiang, W., Yan, X., Liu, Y., & Jiang, B. (2026). Thermally Gated Dual‐Cascade Nanozyme for Enhanced Mild‐Temperature Photothermal Therapy. Advanced Science. https://doi.org/10.1002/advs.202517528

Vancouver

Wang S, Wang S, Cao M, Wang L, Jiang W, Yan X, et al. Thermally Gated Dual‐Cascade Nanozyme for Enhanced Mild‐Temperature Photothermal Therapy. Advanced Science. 2026. doi:10.1002/advs.202517528

BibTeX
@article{Wang2026,
  author = {Wang, Shuyu and Wang, Shenghui and Cao, Mengyuan and Wang, Lulu and Jiang, Wei and Yan, Xiyun and Liu, Ying and Jiang, Bing},
  title = {Thermally Gated Dual‐Cascade Nanozyme for Enhanced Mild‐Temperature Photothermal Therapy},
  journal = {Advanced Science},
  year = {2026},
  doi = {10.1002/advs.202517528}
}
Kostenlos starten →